These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23995837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells.
    Arai T, Kano F, Murata M.
    Genes Cells; 2015 Apr; 20(4):340-57. PubMed ID: 25736587
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.
    Li X, Xu M, Wang F, Kohan AB, Haas MK, Yang Q, Lou D, Obici S, Davidson WS, Tso P.
    J Biol Chem; 2014 Jan 24; 289(4):2396-404. PubMed ID: 24311788
    [Abstract] [Full Text] [Related]

  • 11. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
    Yarushkin AA, Kachaylo EM, Pustylnyak VO.
    Br J Pharmacol; 2013 Apr 24; 168(8):1923-32. PubMed ID: 23231652
    [Abstract] [Full Text] [Related]

  • 12. TRB1 negatively regulates gluconeogenesis by suppressing the transcriptional activity of FOXO1.
    Tsuzuki K, Itoh Y, Inoue Y, Hayashi H.
    FEBS Lett; 2019 Feb 24; 593(3):369-380. PubMed ID: 30556236
    [Abstract] [Full Text] [Related]

  • 13. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
    Cho HM, Seok YM, Lee HA, Song M, Kim I.
    Int J Mol Sci; 2018 Nov 09; 19(11):. PubMed ID: 30424007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells.
    Bumke-Vogt C, Osterhoff MA, Borchert A, Guzman-Perez V, Sarem Z, Birkenfeld AL, Bähr V, Pfeiffer AF.
    PLoS One; 2014 Nov 09; 9(8):e104321. PubMed ID: 25136826
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver.
    Park JM, Kim TH, Bae JS, Kim MY, Kim KS, Ahn YH.
    Biochem Biophys Res Commun; 2010 Dec 17; 403(3-4):329-34. PubMed ID: 21078299
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
    Goyal N, Tiwary S, Kesharwani D, Datta M.
    J Mol Med (Berl); 2019 Jan 17; 97(1):115-126. PubMed ID: 30465059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.